From Brainwaves to Biomedicine: A Resonant Approach to Déjà Vu, Parkinson's, and Cance

This paper proposes a novel hypothesis linking electromagnetic resonance in the brain to déjà vu, Parkinson's disease, and cancer therapy. It suggests that déjà vu may result from resonance between internal brain waves and external electromagnetic stimuli, potentially triggering a sudden alpha-togamma brainwave transition. This phenomenon could open new avenues for non-invasive treatments. In Parkinson's, personalized EMF pulses analyzed via AI may counteract neural rhythm disturbances. For cancer, the theory posits that abnormal cell division emits distinct EM signatures that can be targeted using resonant-frequency therapies. A framework combining EEG, MEG, and fMRI, enhanced by AI, is proposed for mapping these signals. While still conceptual, this approach merges neuroscience, EM theory, and personalized medicine to inspire new research pathways.